Novel study is investigating dysregulation of the complement system during standard hemodialysis therapy in relation to patient health outcomes. GLASGOW, Scotland, June 13, 2023 /PRNewswire/ — Invizius Limited (“Invizius”), a biotechnology company developing second generation therapies…